aTyr Pharma Announces Partner Kyorin Pharmaceutical, Co., Ltd. Proceeds to Phase 1 Trial of ATYR1923 in Japan

Go back to aTyr Pharma Announces Partner Kyorin Pharmaceutical, Co., Ltd. Proceeds to Phase 1 Trial of ATYR1923 in Japan
Life Technologies Corporation (NASDAQ: LIFE) Delayed: 17.18 --0 (-0%)
Previous Close $17.18    52 Week High $10.93 
Open $17.18    52 Week Low $2.48 
Day High $17.18    P/E 6.34 
Day Low $17.18    EPS $2.71 
Volume 1,614